Peripheral chemosensor function is blunted in moderate to severe chronic kidney disease

International Journal of Cardiology

Volumn 155, Issue 2, 2012, Pages 201-205

  Rassaf, Tienush ^a   Schueller, Per ^b   Westenfeld, Ralf ^a   Floege, Jürgen ^a   Eickholt, Christian ^a   Hennersdorf, Marcus ^c   Merx, Marc W ^a   Schauerte, Patrick ^b   Kelm, Malte ^a   Meyer, Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c SLK Kliniken Heilbronn   (Germany)

Author keywords

Chemoreflexes; Chronic kidney disease; Nervous system; Sympathetic

Indexed keywords

CREATININE; OXYGEN;

ADULT; ARTERIAL PRESSURE; ARTICLE; CHEMORECEPTOR REFLEX; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS; RR INTERVAL;

AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; BLOOD PRESSURE; CHEMORECEPTOR CELLS; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SYMPATHETIC NERVOUS SYSTEM;

EID: 84857056314     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.054     Document Type: Article

References (30)

1. O. Wirta, A. Pasternack, J. Mustonen, and P. Laippala Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects Nephrol Dial Transplant 12 1997 2612 2617
2. J. Neumann, G. Ligtenberg, I.I. Klein, H.A. Koomans, and P.J. Blankestijn Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment Kidney Int 65 2004 1568 1576
3. E.L. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease: effects on the cardiovascular system Circulation 116 2007 85 97
4. C. Meyer, O.R. Rana, and E. Saygili Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation Circulation 121 2010 1286 1294
5. C. Kurata, A. Uehara, and T. Sugi Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis Nephron 84 2000 312 319
6. V. Parisotto, E.M. Lima, J.M. Silva, M.R. de Sousa, and A.L. Ribeiro Cardiac sympathetic dysautonomia in children with chronic kidney disease J Nucl Cardiol 15 2008 246 254
7. P. Ponikowski, T.P. Chua, and M. Piepoli Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure Circulation 96 1997 2586 2594
8. H. Schmidt, U. Muller-Werdan, and S. Nuding Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome-the potential role of disease severity Intensive Care Med 30 2004 665 672
9. M.G. Hennersdorf, S. Hillebrand, C. Perings, and B.E. Strauer Chemoreflexsensitivity in chronic heart failure patients Eur J Heart Fail 3 2001 679 684
10. R. Mohan, and J. Duffin The effect of hypoxia on the ventilatory response to carbon dioxide in man Respir Physiol 108 1997 101 115
11. D. Hering, Z. Zdrojewski, and E. Krol Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure J Hypertens 25 2007 157 161
12. M.G. Hennersdorf, V. Niebch, C. Perings, and B.E. Strauer Chemoreflex sensitivity as a predictor of arrhythmia relapse in ICD recipients Int J Cardiol 86 2002 169 175
13. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
14. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
15. C. Meyer, C. Heiss, and C. Drexhage Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function J Am Coll Cardiol 55 2010 454 459
16. T. Rassaf, L.W. Poll, and P. Brouzos Positive effects of nitric oxide on left ventricular function in humans Eur Heart J 27 2006 1699 1705
17. M. Budeus, M. Hennersdorf, and C. Perings Chemoreflexsensitivity among patients with paroxysmal atrial fibrillation Z Kardiol 92 2003 558 563
18. S. Ye, B. Ozgur, and V.M. Campese Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure Kidney Int 51 1997 722 727
19. S. Ye, H. Zhong, V. Yanamadala, and V.M. Campese Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity Am J Hypertens 15 2002 717 724
20. P. Studinger, Z. Lenard, B. Mersich, G.S. Reusz, and M. Kollai Determinants of baroreflex function in juvenile end-stage renal disease Kidney Int 69 2006 2236 2242
21. V.K. Somers, A.L. Mark, and F.M. Abboud Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans J Clin Invest 87 1991 1953 1957
22. G.F. DiBona Neural control of the kidney: past, present, and future Hypertension 41 2003 621 624
23. G.F. DiBona The sympathetic nervous system and hypertension: recent developments Hypertension 43 2004 147 150
24. C. Meyer, O.R. Rana, and E. Saygili Hyperoxic chemoreflex sensitivity is impaired in patients with neurocardiogenic syncope Int J Cardiol 2009
25. M.G. Hennersdorf, C. Perings, V. Niebch, S. Hillebrand, E.G. Vester, and B.E. Strauer Chemoreflexsensitivity in patients with survived sudden cardiac arrest and prior myocardial infarction Pacing Clin Electrophysiol 23 2000 457 462
26. R.R. Wenzel, G. Allegranza, and C. Binggeli Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics J Am Coll Cardiol 29 1997 1607 1614
27. B.G. Wallin, G. Sundlof, E. Stromgren, and H. Aberg Sympathetic outflow to muscles during treatment of hypertension with metoprolol Hypertension 6 1984 557 562
28. J. Neumann, G. Ligtenberg, L. Oey, H.A. Koomans, and P.J. Blankestijn Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure J Am Soc Nephrol 15 2004 2902 2907
29. G. Ligtenberg, P.J. Blankestijn, and P.L. Oey Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure N Engl J Med 340 1999 1321 1328
30. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150